Clinical trial · Observational
A Cohort Establishment Study of Total Management of Ovarian Cancer
A Cohort Establishment Study of Total Management of Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer)
NCT06018935CI-TRIAL-00078094unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Tumor of Female Reproductive System | Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Progress Freesurvival (PFS)
- timeFrame
- Average six months after study completion.
- description
- The time from the start of treatment until the patient progresses further or dies.
- measure
- Overall Survival (OS)
- timeFrame
- Average six months after study completion.
- description
- Measure the time from the start of treatment to the time of death.
Secondary outcomes (1)
- measure
- Occurrence of adverse reactions
- timeFrame
- Average six months after study completion.
- description
- All adverse events were recorded.
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: 1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital; 2. Can cooperate with later follow-up. Exclusion Criteria: 1. Patients with other malignant tumors or previous history of other malignant tumors; 2. Have cognitive impairment.
References
Publications (0)
Data not yet available
No reference posted for this study.